Research rooted in your community
Montana: (406) 763-8833Utah: (385) 392-2200
Boeson Research

Montana & Utah

David N. Taylor, MD, MSc

Portrait of David N. Taylor

David N. Taylor, MD, MSc

Infectious diseases, vaccines & clinical development

Board-certified infectious-disease physician and Bozeman Health Director of Clinical Research. Local PI experience includes Phase 3 influenza and RSV vaccines, Phase 2/3 therapeutics and biorepository research, backed by four decades of research leadership and former Chief Medical Officer roles.

Published site role
  • Bozeman · Principal investigator · Bozeman Health collaboration

Vaccine-development leadership. Proven Bozeman PI experience.

Board-certified Internal Medicine & Infectious Diseases · Director of Clinical Research, Bozeman Health

Dr. David N. Taylor combines more than four decades of clinical research and vaccine-development leadership with hands-on principal investigator experience in Bozeman. For sponsors and CROs, he brings both the perspective of a former Chief Medical Officer and the practical experience of leading local clinical trials.

Clinical trial leadership at Bozeman Health

Director of Clinical Research since 2021, Dr. Taylor has led studies spanning investigational therapeutics, respiratory vaccines and precision medicine:

  • COVID-19 therapeutics: Principal investigator in a Phase 2/3 outpatient adaptive-platform trial and two Phase 2 therapeutic studies.
  • Influenza vaccines: Principal investigator in a Phase 3 modified-RNA seasonal influenza vaccine trial.
  • RSV vaccines: Principal investigator in a Phase 3 RSVpreF vaccine program for adults at high risk of severe RSV disease.
  • Precision medicine: Principal investigator in a prospective biorepository study collecting biospecimens and associated clinical data.
  • Eosinophilic esophagitis: Sub-investigator in Phase 3 and expanded-access programs.

A sponsor’s perspective on clinical development

Dr. Taylor previously served as Chief of the Department of Clinical Trials at Walter Reed Army Institute of Research; Chief Medical Officer at VaxInnate, Vaxart and Salix Pharmaceuticals; Senior Medical Director, Vaccines at Takeda; and Senior Medical Officer in PATH vaccine- and drug-development programs. His earlier biotechnology experience includes Phase 1 and Phase 2 influenza vaccine leadership and medical oversight of human-challenge research.

Scientific depth and clinical credentials

Board certified in Internal Medicine and Infectious Diseases, Dr. Taylor earned his MD at Harvard Medical School and MSc in Medical Parasitology at the London School of Hygiene and Tropical Medicine. His career includes a research professorship at Johns Hopkins, CDC Epidemic Intelligence Service work and international clinical research across Latin America, Asia and Europe.

His academic bibliography includes approximately 180 peer-reviewed journal articles. A Fellow of the American College of Physicians and the Infectious Diseases Society of America, he brings particular depth in adult and older-adult vaccines, infectious diseases, enteric diseases and clinical development.

Choose Bozeman for experienced research leadership: Connect your vaccine, infectious-disease or precision-medicine program with Dr. Taylor through Boeson’s Bozeman Health collaboration.

Availability, current affiliations and protocol-specific roles are confirmed during feasibility review.

Related expertise

Request feasibility
Cookie settings

Advertising tracking is off. Cookie-free Cloudflare Web Analytics measures only generic homepage and About-page visits; recruitment and contact flows are excluded. Necessary hosting, security and contact services support this website. Cloudflare Zaraz manages any optional tools configured for this domain; no optional tools are currently installed.

Research listings and applications use RealTime and separate research consent. Cookie settings do not enroll you in research or withdraw research consent.

No optional tracking choices are required while analytics and advertising are off.

Privacy and cookie notice